Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 3/20 | 0.35 |
| ▸ | POLQ | O75417 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | STAT3 | P40763 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL807976 | 0.87 | SIGMAR1 (0.31) | — | |
| SCHEMBL808247 | 0.85 | STAT3 (0.30) | STAT3 | |
| SCHEMBL10287199 | 0.82 | GABRA5 (0.39) | HDAC4HDAC8HDAC6 | |
| SCHEMBL10287560 | 0.80 | HDAC4 (0.33) | POLQHDAC4HDAC8HDAC6 | |
| SCHEMBL808224 | 0.79 | SIGMAR1 (0.32) | — | |
| SCHEMBL808229 | 0.78 | SIGMAR1 (0.32) | — | |
| SCHEMBL807993 | 0.77 | GRM5 (0.39) | HDAC4HDAC8HDAC6NPC1S1PR1 | |
| SCHEMBL808333 | 0.76 | NPC1 (0.37) | LIPECASP3HDAC4HDAC8HDAC6 | |
| SCHEMBL807994 | 0.76 | SIGMAR1 (0.31) | — | |
| SCHEMBL10287782 | 0.76 | MAOB (0.36) | KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012035023-A1 | TRIAZINE-OXADIAZOLES | NOVARTIS AG (CH) | 2012-03-22 | — | — | WO | disclosed |